{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:19:10Z","timestamp":1783487950029,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12020-021-02835-6","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T12:02:46Z","timestamp":1627646566000},"page":"666-675","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Bone and body composition analyses by DXA in adults with GH deficiency: effects of long-term replacement therapy"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4769-0729","authenticated-orcid":false,"given":"Alessandro","family":"Rossini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Lanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Galeone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pelucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Pennacchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Perticone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Sirtori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Losa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rubinacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"key":"2835_CR1","doi-asserted-by":"publisher","first-page":"695e700","DOI":"10.1530\/EJE-07-0631","volume":"157","author":"KK Ho","year":"2007","unstructured":"K.K. Ho, Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157, 695e700 (2007)","journal-title":"Eur J Endocrinol"},{"key":"2835_CR2","first-page":"669e74","volume":"78","author":"SJ Holmes","year":"1994","unstructured":"S.J. Holmes, G. Economou, R.W. Whitehouse et al. Reduced bone mineral density in patients with adult-onset growth hormone deficiency. J Clin Endocrinol Metab 78, 669e74 (1994)","journal-title":"J Clin Endocrinol Metab"},{"key":"2835_CR3","first-page":"25","volume":"2","author":"B Angelin","year":"1995","unstructured":"B. Angelin, M. Rudling, Growth hormone and lipoprotein metabolism. Endocrinol Metab 2, 25\u201328 (1995)","journal-title":"Endocrinol Metab"},{"key":"2835_CR4","first-page":"E 499","volume":"260","author":"DA Fryburg","year":"1991","unstructured":"D.A. Fryburg, R.A. Gelfand, E.J. Barrett, Growth hormone acutely stimulates muscle protein synthesis in normal humans. Am J Physiol 260, E 499\u2013E 504 (1991)","journal-title":"Am J Physiol"},{"key":"2835_CR5","first-page":"4344","volume":"83","author":"DM Hoffman","year":"1998","unstructured":"D.M. Hoffman, R. Pallasser, M. Duncan et al. How is whole body protein turnover perturbed in growth hormone deficient adults? J Clin Endocrinol Metab 83, 4344\u20134349 (1998)","journal-title":"J Clin Endocrinol Metab"},{"key":"2835_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.beem.2017.02.002","volume":"31","author":"NA Tritos","year":"2017","unstructured":"N.A. Tritos, Focus on growth hormone deficiency and bone in adults. Best Pract Res Clin Endocrinol Metab 31, 49\u201357 (2017)","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2835_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12020-015-0738-z","volume":"52","author":"G Mazziotti","year":"2016","unstructured":"G. Mazziotti, M. Doga, S. Frara, F. Maffezzoni, T. Porcelli, L. Cerri, R. Maroldi, A. Giustina, Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency. Endocrine. 52, 103\u2013110 (2016)","journal-title":"Endocrine."},{"key":"2835_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12020-014-0327-6","volume":"48","author":"J Isgaard","year":"2015","unstructured":"J. Isgaard, M. Arcopinto, K. Karason, A. Cittadini, GH and the cardiovascular system: an update on a topic at heart. Endocrine 48, 25\u201335 (2015)","journal-title":"Endocrine"},{"key":"2835_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S2213-8587(15)00098-4","volume":"3","author":"D Mo","year":"2015","unstructured":"D. Mo, M. Fleseriu, R. Qi, N. Jia, C.J. Child, R. Bouillon, D.S. Hardin, Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study. Lancet Diabetes Endocrinol 3, 331\u2013338 (2015)","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2835_CR10","first-page":"30040","volume":"S0003-4266","author":"P Chanson","year":"2020","unstructured":"P. Chanson, The heart in growth hormone (GH) deficiency and the cardiovascular effects of GH. Ann Endocrinol S0003-4266, 30040\u201330048 (2020). Online ahead of print","journal-title":"Ann Endocrinol"},{"key":"2835_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ghir.2008.07.001","volume":"19","author":"C Franco","year":"2009","unstructured":"C. Franco, J. Koranyi, J. Brandberg, L. L\u00f6on, B.K. Bengtsson, J. Svensson, G. Johannsson, The reduction in visceral fat mass in response to growth hormone is more marked in men than in oestrogen deficient women. Growth Horm IGF Res 19, 112\u2013120 (2009)","journal-title":"Growth Horm IGF Res"},{"key":"2835_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1210\/jcem.82.2.3776","volume":"82","author":"P Burman","year":"1997","unstructured":"P. Burman, A.G. Johansson, A. Siegbahn, B. Vessby, F.A. Karlsson, Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 82, 550\u2013555 (1997). https:\/\/doi.org\/10.1210\/jcem.82.2.3776","journal-title":"J Clin Endocrinol Metab"},{"key":"2835_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1530\/eje.1.02017","volume":"153","author":"A Mukherjee","year":"2005","unstructured":"A. Mukherjee, J.E. Adams, L. Smethurst, S.M. Shalet, Interdependence of lean body mass and total body water, but not quality of life measures, during low dose GH replacement in GH-deficient adults. Eur J Endocrinol 153, 661\u2013668 (2005). https:\/\/doi.org\/10.1530\/eje.1.02017","journal-title":"Eur J Endocrinol"},{"key":"2835_CR14","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1161\/01.CIR.0000100720.01867.1D","volume":"108","author":"P Maison","year":"2003","unstructured":"P. Maison, P. Chanson, Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis. Circulation 108, 2648\u20132652 (2003)","journal-title":"Circulation"},{"issue":"Jul 1","key":"2835_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1530\/EJE-19-0132","volume":"181","author":"A Ziagaki","year":"2019","unstructured":"A. Ziagaki, D. Blaschke, W. Haverkamp, U. Pl\u00f6ckinger, Long-term growth hormone (GH) replacement of adult GH deficiency (GHD) benefits the heart. Eur J Endocrinol 181(Jul 1), 79\u201391 (2019)","journal-title":"Eur J Endocrinol"},{"key":"2835_CR16","doi-asserted-by":"publisher","first-page":"727e35","DOI":"10.1111\/cen.12493","volume":"81","author":"NM Appelman-Dijkstra","year":"2014","unstructured":"N.M. Appelman-Dijkstra, K.M. Claessen, N.A. Hamdy et al. Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study. Clin Endocrinol 81, 727e35 (2014)","journal-title":"Clin Endocrinol"},{"key":"2835_CR17","doi-asserted-by":"publisher","first-page":"852e60","DOI":"10.1210\/jc.2013-3921","volume":"99","author":"M Barake","year":"2014","unstructured":"M. Barake, A. Klibanski, N.A. Tritos, Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis. J Clin Endocrinol Metab 99, 852e60 (2014)","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2835_CR18","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1385\/ENDO:12:2:163","volume":"12","author":"AL Carrel","year":"2000","unstructured":"A.L. Carrel, D.B. Allen, Effects of growth hormone on body composition and bone metabolism. Endocrine 12(2), 163\u2013172 (2000)","journal-title":"Endocrine"},{"key":"2835_CR19","doi-asserted-by":"publisher","first-page":"92e8","DOI":"10.1111\/j.1365-2265.2004.01935.x","volume":"60","author":"P Davidson","year":"2004","unstructured":"P. Davidson, R. Milne, D. Chase et al. Growth hormone replacement in adults and bone mineral density: a systematic review and meta-analysis. Clin Endocrinol 60, 92e8 (2004)","journal-title":"Clin Endocrinol"},{"key":"2835_CR20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1530\/EJE-11-1072","volume":"166","author":"M Elbornsson","year":"2012","unstructured":"M. Elbornsson, G. Gotherstrom, I. Bosaeus et al. Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency. Eur J Endocrinol 166, 787\u2013795 (2012)","journal-title":"Eur J Endocrinol"},{"key":"2835_CR21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1530\/EJE-12-1083","volume":"168","author":"M Elbornsson","year":"2013","unstructured":"M. Elbornsson, G. Gotherstrom, I. Bos\u00e6us, B.A. Bengtsson, G. Johannsson, J. Svensson, Fifteen years of GH replacement improves body composition and cardiovascular risk factors. Eur J Endocrinol 168, 745\u2013753 (2013)","journal-title":"Eur J Endocrinol"},{"key":"2835_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00223-010-9459-8","volume":"88","author":"A Rossini","year":"2011","unstructured":"A. Rossini, R. Lanzi, M. Losa et al. Predictors of bone responsiveness to growth hormone (GH) replacement in adult GH-deficient patients. Calcif Tissue Int 88, 304\u2013313 (2011)","journal-title":"Calcif Tissue Int"},{"key":"2835_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1530\/eje.1.02317","volume":"156","author":"G G\u00f6therstr\u00f6m","year":"2007","unstructured":"G. G\u00f6therstr\u00f6m, B.A. Bengtsson, I. Bosaeus, G. Johannsson, J. Svensson, G.H. Ten-year, replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency. Eur J Endocrinol 156, 55\u201364 (2007)","journal-title":"Eur J Endocrinol"},{"key":"2835_CR24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/cen.12132","volume":"79","author":"NA Tritos","year":"2013","unstructured":"N.A. Tritos, A.H. Hamrahian, D. King, S.L. Greenspan, D.M. Cook, P.J. J\u00f6nsson, M. Koltowska-H\u00e4ggstrom, B.M. Biller, Predictors of the effects of 4 years of growth hormone replacement on bone mineral density in patients with adult-onset growth hormone deficiency \u2013 a KIMS database analysis. Clin Endocrinol 79, 178\u2013184 (2013)","journal-title":"Clin Endocrinol"},{"issue":"2","key":"2835_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1530\/eje.1.01967","volume":"153","author":"G Corneli","year":"2005","unstructured":"G. Corneli, C. Di Somma, R. Baldelli et al. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol 153(2), 257\u2013264 (2005)","journal-title":"Eur J Endocrinol"},{"key":"2835_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jocd.2007.12.007","volume":"11","author":"S Baim","year":"2008","unstructured":"S. Baim, N. Binkley, J.P. Bilezikian, D.L. Kendler, D.B. Hans, E.M. Lewiecki, S. Silverman, Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom 11, 75\u2013791 (2008)","journal-title":"J Clin Densitom"},{"key":"2835_CR27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.orcp.2020.10.005","volume":"14","author":"YM Cheung","year":"2020","unstructured":"Y.M. Cheung, G. Roff, M. Grossmann, Precision of the hologic horizon A dual energy X-ray absorptiometry in the assessment of body composition. Obes Res Clin Pract. 14, 514\u2013518 (2020). https:\/\/doi.org\/10.1016\/j.orcp.2020.10.005. Epub 2020 Oct 31. PMID: 33132075","journal-title":"Obes Res Clin Pract."},{"key":"2835_CR28","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/jbmr.3641","volume":"34","author":"ML Bouxsein","year":"2019","unstructured":"M.L. Bouxsein, R. Eastell, L.Y. Lui, L.A. Wu, A.E. de Papp, A. Grauer, F. Marin, J.A. Cauley, D.C. Bauer, D.M. Black, FNIH Bone Quality Project. Change in bone density and reduction in fracture risk: a meta-regression of published trials. J Bone Miner Res 34, 632\u2013642 (2019). https:\/\/doi.org\/10.1002\/jbmr.3641","journal-title":"J Bone Miner Res"},{"key":"2835_CR29","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1210\/jcem.86.10.7887","volume":"86","author":"G Gotherstrom","year":"2001","unstructured":"G. Gotherstrom, J. Svensson, J. Koranyi, M. Alpsten, I. Bosaeus, B. Bengtsson, G. Johannsson, A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. J Clin Endocrinol Metab 86, 4657\u20134665 (2001)","journal-title":"J Clin Endocrinol Metab"},{"key":"2835_CR30","doi-asserted-by":"publisher","first-page":"e1552","DOI":"10.1210\/clinem\/dgaa963","volume":"106","author":"S Yuan","year":"2021","unstructured":"S. Yuan, Z.H. Wan, S.L. Cheng, K. Micha\u00eblsson, S.C. Larsson, Insulin-like growth factor-1, bone mineral density, and fracture: a mendelian randomization study. J Clin Endocrinol Metab 106, e1552\u2013e1558 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgaa963","journal-title":"J Clin Endocrinol Metab"},{"key":"2835_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1530\/eje.0.1480185","volume":"148","author":"R Lanzi","year":"2003","unstructured":"R. Lanzi, M. Losa, I. Villa, E. Gatti, M. Sirtori, F.C. Dal, A. Rubinacci, GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults. Eur J Endocrinol 148, 185\u2013191 (2003)","journal-title":"Eur J Endocrinol"},{"key":"2835_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1677\/joe.1.07073","volume":"192","author":"E Mrak","year":"2007","unstructured":"E. Mrak, I. Villa, R. Lanzi, M. Losa, F. Guidobono, A. Rubinacci, Growth hormone stimulates osteoprotegerin expression and secretion in human osteoblast-like cells. J Endocrinol 192, 639\u2013645 (2007)","journal-title":"J Endocrinol"},{"key":"2835_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1365-2265.2002.01582.x","volume":"57","author":"B Abrahamsen","year":"2002","unstructured":"B. Abrahamsen, J. Hangaard, H.C. Horn, T.B. Hansen, G. Gregersen, M. Hansen- Nord, N. Vahl, P. Junker, M. Andersen, C. Hagen, Evaluation of the optimum dose of growth hormone (GH) for restoring bone mass in adult-onset GH deficiency: results from two 12-month randomized studies. Clin Endocrinol 57, 273\u2013281 (2002)","journal-title":"Clin Endocrinol"},{"key":"2835_CR34","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3171\/2016.8.JNS161123","volume":"126","author":"EH Oldfield","year":"2017","unstructured":"E.H. Oldfield, J.A. Jane Jr, M.O. Thorner, C.L. Pledger, J.P. Sheehan, M.L. Vance, Correlation between GH and IGF-1 during treatment for acromegaly. J Neurosurg 126, 1959\u20131966 (2017). https:\/\/doi.org\/10.3171\/2016.8.JNS161123","journal-title":"J Neurosurg"},{"key":"2835_CR35","doi-asserted-by":"publisher","first-page":"dgz254","DOI":"10.1210\/clinem\/dgz254","volume":"105","author":"Z Pekkolay","year":"2020","unstructured":"Z. Pekkolay, F. K\u0131l\u0131n\u00e7, N. Gozel, E. \u00d6nalan, A.K. Tuzcu, Increased serum sclerostin levels in patients with active Acromegaly. J Clin Endocrinol Metab 105, dgz254 (2020)","journal-title":"J Clin Endocrinol Metab"},{"key":"2835_CR36","doi-asserted-by":"publisher","first-page":"14e36","DOI":"10.1016\/j.mce.2015.10.017","volume":"432","author":"MR Laurent","year":"2016","unstructured":"M.R. Laurent, V. Dubois, F. Claessens, S.M.P. Verschueren, D. Vanderschueren, E. Gielen, F. Jard\u00ed, Muscle-bone interactions: From experimental models to the clinic? A critical update. Mol Cell Endocrinol 432, 14e36 (2016)","journal-title":"Mol Cell Endocrinol"},{"key":"2835_CR37","first-page":"1038","volume":"826","author":"H Kaji","year":"2016","unstructured":"H. Kaji, Effects of myokines on bone. Bonekey Rep 826, 1038\u20131044 (2016)","journal-title":"Bonekey Rep"},{"key":"2835_CR38","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1530\/eje.1.02118","volume":"154","author":"J Koranyi","year":"2006","unstructured":"J. Koranyi, I. Bosaeus, M. Alpsten, B.A. Bengtsson, G. Johannsson, Body composition during GH replacement in adults - methodological variations with respect to gender. Eur J Endocrinol 154, 545\u2013553 (2006). https:\/\/doi.org\/10.1530\/eje.1.02118","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2835_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000499430","volume":"109","author":"MR Postma","year":"2019","unstructured":"M.R. Postma, A.P. van Beek, P.J. J\u00f6nsson, C.C. van Bunderen, M.L. Drent, A.F. Mattsson, C. Camacho-Hubner, Improvements in body composition after 4 years of growth hormone treatment in adult-onset hypopituitarism compared to age-matched controls. Neuroendocrinology 109(2), 131\u2013140 (2019)","journal-title":"Neuroendocrinology"},{"key":"2835_CR40","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.beem.2017.03.003","volume":"31","author":"V Birzniece","year":"2017","unstructured":"V. Birzniece, K.K. Ho, Sex steroids and the GH axis: implications for the management of hypopituitarism. Best Pract Res Clin Endocrinol Metabol 31, 59\u201369 (2017)","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"2835_CR41","doi-asserted-by":"publisher","first-page":"E266","DOI":"10.1152\/ajpendo.00483.2004","volume":"289","author":"J Gibney","year":"2005","unstructured":"J. Gibney, T. Wolthers, G. Johannsson, A.M. Umpleby, K.K. Ho, Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. Am J Physiol Endocrinol Metab 289, E266\u2013E271 (2005)","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2835_CR42","first-page":"S9","volume":"41","author":"SL Bonnick","year":"2007","unstructured":"S.L. Bonnick, HSA: beyond BMD with DXA. Bone 41, S9\u2013S12 (2007)","journal-title":"Bone"},{"key":"2835_CR43","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1359\/jbmr.2001.16.12.2320","volume":"16","author":"D Bikle","year":"2001","unstructured":"D. Bikle, S. Majumdar, A. Laib, L. Powell-Braxton, C. Rosen, W. Beamer, E. Nauman, C. Leary, B. Halloran, The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res 16, 2320\u20132329 (2001)","journal-title":"J Bone Miner Res"},{"key":"2835_CR44","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1210\/endo.141.7.7585","volume":"141","author":"G Zhao","year":"2000","unstructured":"G. Zhao, M.C. Monier-Faugere, M.C. Langub, Z. Geng, T. Nakayama, J.W. Pike, S.D. Chernausek, C.J. Rosen, L.R. Donahue, H.H. Malluche, J.A. Fagin, T.L. Clemens, Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology. 141, 2674\u20132682 (2000)","journal-title":"Endocrinology."},{"issue":"1","key":"2835_CR45","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1210\/jc.2012-2940","volume":"98","author":"KM Claessen","year":"2013","unstructured":"K.M. Claessen, N.M. Appelman-Dijkstra, D.M. Adoptie, F. Roelfsema, J.W. Smit, N.R. Biermasz, A.M. Pereira, Metabolic profile in growth hormone- deficient (GHD) adults after long-term recombinant human growth hormone (rhGH) therapy. J Clin Endocrinol Metab 98(1), 352\u2013361 (2013)","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02835-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02835-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02835-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T09:14:51Z","timestamp":1636103691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02835-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2835"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02835-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-260021\/v1","asserted-by":"object"}]},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,30]]},"assertion":[{"value":"19 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"patients gave standard written informed consent to the use of their anonymized clinical data for research purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and consent for publication"}},{"value":"This is an observational study. The San Raffaele Scientific Institute Research Ethics Committee has confirmed that no ethical approval is required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}